MCC Codes
5122

Drugs, Drug Proprietaries, and Druggist Sundries

A guide for underwriters at ISOs and Acquirers onboarding MCC 5122 pharmaceutical wholesale and distribution merchants, covering risk assessment, fraud signals, and the underwriting questions that matter.
View All MCCs

Using this for underwriting? Run the numbers with our Onboarding Calculator.

Table of Contents
Overview
Business Types
Payment Processing Info
Key Risks & Concerns
Common Fraud Signals
Example Scenarios
Common Questions
Ongoing Monitoring
Useful Sources

Underwriting Cheat Sheet

If you're underwriting a drug and druggist sundries distributor, MCC 5122 sits in high-risk territory where wholesale pharmaceutical distribution, controlled-substance handling, and large B2B transactions create diversion, regulatory, and high-ticket fraud exposure. DEA registration and state licensing are gating requirements, not afterthoughts. Here's what to look for.

Key Information

This guide covers wholesale drugs, drug proprietaries, and druggist sundries, a regulated category where controlled-substance distribution, large B2B transactions, and licensing requirements drive compliance and fraud exposure.

Typical Business Types

Pharmaceutical Wholesalers

#1
Distributors supplying pharmacies and healthcare providers.

Druggist Sundries Suppliers

#2
Sellers of non-drug pharmacy supplies and proprietaries.

Specialty Drug Distributors

#3
Handlers of high-value or controlled medications.

Payment Processing Information

Transaction Types

1

Wholesale Bulk Orders

Large B2B purchases of pharmaceutical products.
2

Controlled-Substance Shipments

Regulated orders requiring DEA documentation.
3

Recurring Account Billing

Standing orders to pharmacy and provider accounts.
4

High-Value Single Invoices

Large transactions for specialty medications.
5

Sundries and Supply Sales

Lower-value non-drug pharmacy supplies.

Common Payment Methods

ACH and Bank Transfer - Dominant for large wholesale invoices
Business and Corporate Cards - Used by pharmacy and provider accounts
Invoicing and Net Terms - Standard B2B billing arrangements
Credit and Debit Cards - Used on smaller orders and sundries
Wire Transfer - Used on large specialty drug transactions

Underwriting MCC

5122

at scale?

See how Gratify automates the risk assessment and gets applications decision-ready in minutes.
Get a 15min Demo

Key Risks & Concerns

Fraud Risks

  • Drug Diversion - Controlled substances rerouted outside legitimate channels
  • Account Takeover - Compromised B2B accounts placing fraudulent orders
  • High-Value CNP Fraud - Large orders placed with stolen payment credentials
  • Counterfeit Product Fraud - Falsified medications entering distribution
  • Identity Fraud - Fake pharmacy credentials used to obtain supply

Regulatory Challenges

  • DEA Registration and Controls - Registration and recordkeeping for controlled substances
  • FDA Drug Supply Chain Security Act - Track-and-trace of pharmaceutical products
  • State Wholesale Drug Licensing - Licensing for distribution in each state
  • Suspicious Order Monitoring - Mandatory detection and reporting of unusual orders
  • PCI Compliance - Payment card data security

Common Fraud Signals

Large B2B Transaction Volume

Revenue dominated by high-value wholesale invoices.

Controlled-Substance Order Share

Meaningful volume in DEA-regulated products.

High-Value Single Invoices

Large individual transactions common in the category.

Example Scenarios and Red Flags

Unusual Controlled-Substance Orders

Orders inconsistent with a buyer's normal pattern.

New Account Large First Order

Big initial orders from unverified accounts.

Credential or License Mismatches

Buyer pharmacy licenses that do not verify.

Diversion Pattern Indicators

Orders sized or routed to suggest diversion.

Account Takeover Order Spikes

Sudden volume jumps on an existing account.

Common Underwriting Questions

UW Tips Business

  1. Verify DEA registration and state wholesale drug licensing
  2. Confirm DSCSA track-and-trace compliance
  3. Assess controlled-substance share of the business

UW Tips Financial

  1. Recognize large B2B invoice and recurring-account structure
  2. Review controlled versus non-controlled product mix
  3. Estimate high-value single-invoice frequency

UW Tips Risk

  1. Examine suspicious order monitoring controls
  2. Evaluate buyer credential and license verification
  3. Review diversion-prevention and reporting procedures

UW Questions Business

  1. Do you hold DEA registration and state wholesale licenses?
  2. What share of volume is controlled substances?
  3. Who are your buyers and how are they verified?

UW Questions Payments

  1. What share of payments is ACH and wire versus card?
  2. How do you process large B2B invoices?
  3. How do you handle recurring account billing?

UW Questions Fraud

  1. How do you run suspicious order monitoring?
  2. How do you verify buyer pharmacy credentials?
  3. What protects against B2B account takeover?

UW Questions Compliance

  1. How do you comply with DEA controlled-substance rules?
  2. Are you DSCSA track-and-trace compliant?
  3. Do you hold wholesale licensing in each state served?

UW Questions Chargebacks

  1. What is your dispute rate on large invoices?
  2. How do you document delivery and chain of custody?
  3. How do you handle disputed high-value orders?

UW Questions Infrastructure

  1. Is your order system integrated with track-and-trace?
  2. How do you log controlled-substance transactions?
  3. Do you have backup systems for order records?

Ongoing Monitoring

Transaction Monitoring

  • Run suspicious order monitoring on controlled products
  • Track new-account large first orders
  • Watch account-takeover volume spikes

Compliance Checks

  • Maintain DEA registration and DSCSA compliance
  • Keep state wholesale licensing current
  • File required suspicious order reports

Security Updates

  • Apply strong authentication on B2B accounts
  • Use encryption and tokenization for payment data
  • Verify buyer credentials before fulfilling orders

Risk Assessment

  • Apply enhanced monitoring on controlled-substance orders
  • Verify credentials before large or new-account orders
  • Hold reserves against high-value invoice disputes

Merchant Communication

Help the merchant align payment controls with DEA and DSCSA obligations. Share suspicious order monitoring and credential verification practices. Support secure handling of large B2B transactions and account access.

Overwhelmed with Applications?

Gratify offers instant merchant application enrichment to get the full picture of your customers in real-time
Learn about the fast way to onboard merchants

Useful Sources

Visa Merchant Data Standards Manual

PCI DSS Quick Reference

DEA Diversion Control Division Registrant Requirements

Level up your Onboarding game with Gratify

Everyday we talk to experts in payments, underwriting and merchant onboarding. They share their insights with us, and we want to share them with you.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tick Icon
Stay Updated
Tick Icon
1 email per week
Gratify merchant onboarding platform
LinkedIn
Industries
Retail ISO
Wholesale ISO
PayFac
Acquirer
White label BNPL
Product
Statement AnalyzerSmart FormsKYB & KYCUnderwriting AutomationOnboarding AutomationRevenue Assurance
Resources
MCC LookupBlog2026 State of Merchant OnboardingOnboarding CalculatorOnboarding Checklist
Comparison
Gratify vs BallerineGratify vs LegitScriptGratify vs NMI ScanX
Company
About UsContact UsPrivacy PolicyCookie Policy
© 2026 Gratify Payments Inc.